Nuveen Churchill Private Capital Income Fund 8-K

What Happened

• On March 2, 2026 the Nuveen Churchill Private Capital Income Fund filed an 8‑K providing its monthly valuation and portfolio update as of January 31, 2026, and announcing regular distributions declared by the board on February 25, 2026.
• NAV per share (Jan. 31, 2026): Class I $24.28, Class S $24.21, Class D $24.28. Aggregate NAV ≈ $1.4 billion; fair value of the investment portfolio ≈ $2.2 billion; secured borrowings outstanding $785.0 million.

Key Details

• Distributions: Board declared gross regular distributions of $0.170 per share for Class I, S and D; net payable amounts per share — Class I $0.170, Class S $0.153 (after $0.017 servicing fee), Class D $0.165 (after $0.005 servicing fee). Record date Feb 28, 2026; payment on or about Mar 27, 2026.
• Portfolio size & composition: Investments in 324 portfolio companies; $2.2 billion in investments (at cost); average position size 0.31% of portfolio (fair value). By fair value: 93.03% first‑lien debt, 2.82% second‑lien, 2.17% mezzanine/structured debt, 1.98% equity.
• Yield & interest rate exposure: Weighted average yield on debt and income producing investments (fair value) 8.69% (8.65% including non‑accruals); 95.83% of debt investments bear floating rates.
• Performance snapshot (as of Jan. 31, 2026): Class I 1‑year return 7.50%, since inception (Mar. 30, 2022) 11.02% annualized; Class S and D show similar short‑term returns and since‑inception figures for classes launched Oct. 2, 2023 (~9.52% and 10.37% since inception, respectively).
• Top sectors and holdings: Largest sector weights include Services: Business 18.34% and Healthcare & Pharmaceuticals 14.37%. Top ten holdings each represent ~0.9%–1.35% of fair value (largest: Healthspan Buyer/Thorne HealthTech ~1.35%).

Why It Matters

• The filing gives investors updated NAVs, portfolio size, leverage ($785M secured borrowings) and portfolio composition—key inputs for assessing income potential, interest‑rate sensitivity (high floating‑rate exposure) and credit risk (heavy first‑lien debt concentration).
• The declared distributions and payment schedule are material for income investors. The adviser’s valuation determinations are subject to Board oversight and the data is unaudited and may differ from figures in the Fund’s upcoming Form 10‑Q, so investors should not rely solely on this 8‑K for final financial results.